In addition, we found a significant decrease of NKG2D and DNAM-1 expression on NK cells in GC patients compared to healthy donors, whereas there was no significant difference in NKG2D and DNAM-1 expression between FcεRI-γ-deficient NK cells and conventional NK cells [26]. This evidence concerns the gene KLRK1 and gastric cancer.